{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:39:23Z","timestamp":1762875563627},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Assessment of the bleeding risk of antithrombotic agents is usually performed in healthy animals with some form of vascular injury to peripheral organs to induce bleeding. However, bleeding observed in patients with currently marketed antithrombotic drugs is typically spontaneous in nature such as intracranial haemorrhage (ICH) and gastrointestinal (GI) bleeding, which happens most frequently on top of preexisting pathologies such as GI ulcerations and polyps. Apc\n          min\/+ mice are reported to develop multiple adenomas through the entire intestinal tract and display progressive anaemia. In this study, we evaluated the potential utility of Apc\n          min\/+ mice as a model for assessing spontaneous GI bleeding with antithrombotic agents. Apc\n          min\/+ mice exhibited progressive blood loss starting at the age of nine weeks. Despite the increase in bleeding, Apc\n          min\/+ mice were in a hypercoagulable state and displayed an age-dependent increase in thrombin generation and circulating fibrinogen as well as a significant decrease in clotting times. We evaluated the effect of warfarin, dabigatran etexilate, apixaban and clopidogrel in this model by administering them in diet or in the drinking water to mice for 1\u20134 weeks. All of these marketed drugs significantly increased GI bleeding in Apc\n          min\/+ mice, but not in wild-type mice. Although different exposure profiles of these antithrombotic agents make it challenging to compare the bleeding risk of compounds, our results indicate that the Apc\n          min\/+ mouse may be a sensitive preclinical model for assessing the spontaneous GI bleeding risk of novel antithrombotic agents.<\/jats:p>","DOI":"10.1160\/th13-11-0926","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T12:47:21Z","timestamp":1389876441000},"page":"1121-1132","source":"Crossref","is-referenced-by-count":6,"title":["A novel approach to assess the spontaneous gastrointestinal bleeding risk of antithrombotic agents using Apc\n          min\/+ mice"],"prefix":"10.1160","volume":"111","author":[{"given":"Huijun","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Shang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CarolAnn","family":"Keohane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"O\u2019Neill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Chintala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"JW Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"SJ Connolly","year":"2009","journal-title":"New Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1160\/TH12-02-0093","article-title":"An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation","volume":"108","author":"S Mantha","year":"2012","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1182\/blood-2012-10-461459","article-title":"Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice","volume":"121","author":"M Morowski","year":"2013","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1055\/s-0038-1650654","article-title":"In vivo studies of activated porcine factor VIII","volume":"76","author":"JD Littlewood","year":"1996","journal-title":"Thromb Haemost"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1016\/S1051-0443(95)71243-X","article-title":"Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding","volume":"06","author":"JI Weitz","year":"1995","journal-title":"J Vasc Interv Radiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/01.fjc.0000179000.93154.e0","article-title":"The antithrombotic effect of melagatran in combination with clopidogrel and\/or aspirin (carotid artery primary thrombosis study)","volume":"46","author":"TT Hong","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V77.12.2547.2547","article-title":"The bleeding time does not predict surgical bleeding","volume":"77","author":"SE Lind","year":"1991","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9343(84)90707-1","article-title":"Prolonged bleeding time","volume":"77","author":"SE Lind","year":"1984","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1002658","article-title":"A critical reappraisal of the bleeding time","volume":"16","author":"RP Rodgers","year":"1990","journal-title":"Seminars Thromb Haemost"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1055\/s-0037-1614908","article-title":"SM-20302, a nonpeptide GPIIb\/IIIa receptor antagonist, exhibits a wide therapeutic window in a newly developed haemorrhage model in mice","volume":"82","author":"S Horisawa","year":"1999","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2036.1992.tb00546.x","article-title":"A comparison of indomethacin with ibuprofen on gastrointestinal mucosal integrity in conventional and germ-free rats","volume":"06","author":"R Melarange","year":"1992","journal-title":"Alimentary Pharmacol Therap"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.2296722","article-title":"A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse","volume":"247","author":"AR Moser","year":"1990","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","article-title":"Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-\/- colon carcinoma","volume":"275","author":"V Korinek","year":"1997","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1126\/science.275.5307.1787","article-title":"Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC","volume":"275","author":"PJ Morin","year":"1997","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/ATVBAHA.110.203414","article-title":"SCH 602539, a protease-activated receptor-1 antagonist, inhibits thrombosis alone and in combination with cangrelor in a Folts model of arterial thrombosis in cynomolgus monkeys","volume":"30","author":"M Chintala","year":"2010","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"ref18","first-page":"6090","article-title":"Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands","volume":"63","author":"N Niho","year":"2003","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jpba.2006.03.019","article-title":"Study on warfarin plasma concentration and its correlation with international normalized ratio","volume":"42","author":"S Sun","year":"2006","journal-title":"J Pharm Biomed Analysis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1185\/03007995.2011.654109","article-title":"Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification","volume":"28","author":"A Clemens","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1160\/TH09-11-0758","article-title":"Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity","volume":"103","author":"J van Ryn","year":"2010","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/clpt.2010.106","article-title":"Quantification of apixaban\u2019s therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose","volume":"88","author":"TA Leil","year":"2010","journal-title":"Clin Pharmacol Therap"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH13-11-0926.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:12:19Z","timestamp":1685535139000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH13-11-0926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":21,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2017,11,17]]},"published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1160\/th13-11-0926","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}